Analysis: India cancer ruling opens door for cheaper drugs – Reuters
"This could well be the first of many compulsory rulings here," said Gopakumar G. Nair, head of patent law firm Gopakumar Nair Associates and former president of the Indian Drug Manufacturers' Association. "Global pharmaceutical manufacturers ...
Subscribe to LegalLaw247.Com Newsletter